Liposomes containing doxorubicin and NGR peptide targeting aminopeptidase N, a marker of angiogenic endothelial cells, were used to treat neuroblastoma (NB) in SCID mice (Pastorino et al., 2003). The gene discussed is RTN4R; the disease is neuroblastoma.